Fully illegal with no decriminalization (a 2023 bill has not become law). Medical access is essentially limited to named exemptions for pharmaceutical products (Sativex, Epidyolex) — there is no real domestic medical cannabis program.
Cannabis remains fully illegal in Iceland, with no decriminalization or legalization in force. A bill to decriminalize possession of drugs, including cannabis, in quantities suitable for personal use passed its first reading in the Althingi (Iceland's parliament) in 2023, but as of mid-2026 it has not been enacted into law and its progress has stalled (The Cannigma). Separate proposals to legalize recreational cannabis production, sale, and consumption have also been introduced by individual MPs, including a Reform Party proposal, but none have gained enough support to pass (Volteface).
Because no decriminalization has actually taken effect, cannabis possession, use, and sale remain prosecutable offenses under Iceland's general narcotics law, and travelers should not treat the pending 2023 bill as reflecting current practice.
Iceland has no general medical cannabis program. Legal access is limited to individual exemption permits issued by Iceland's medicines agency, Lyfjastofnun, for specific licensed pharmaceutical products — there is no pathway to cannabis flower. Sativex is authorized and can be prescribed by specialist neurologists for its approved indication (MS-related spasticity). Epidyolex (cannabidiol oral solution) is authorized for treatment-resistant epilepsy. Physicians can also apply to Lyfjastofnun for access to other cannabis-based medicines approved abroad, on a case-by-case basis, but this does not extend to raw flower or the typical oil products used in broader medical cannabis programs elsewhere in Europe.
A medical cannabis pilot project was proposed around 2023 that would have allowed more doctors to prescribe cannabis-based medication for a wider range of conditions, moving beyond the Sativex/Epidyolex-only framework (Cannabis Health News). As of the most recent available information, this pilot has been postponed with no confirmed implementation timeline.
No official Icelandic statement specifically addressing foreign patients traveling with prescribed cannabis-based medicines was found in available sources. Iceland participates in the Schengen area, so the Article 75 certificate framework should apply in principle to registered medicines such as Sativex or Epidyolex prescribed in another Schengen country. However, because Iceland's own domestic system is narrowly limited to these specific pharmaceutical products with no allowance for flower-based medicine, travelers carrying flower-based or non-standard cannabis products should treat entry as high-risk and unconfirmed — this is a materially stricter situation than in countries with broader medical cannabis programs. Anyone needing to bring prescribed cannabis medicine into Iceland should contact Lyfjastofnun directly well before travel to confirm requirements.
Is cannabis decriminalized in Iceland now?
No. A 2023 bill passed its first reading but has not become law as of mid-2026 — cannabis remains fully illegal.
Can I get medical cannabis flower in Iceland?
No. Legal access is limited to specific pharmaceutical products (Sativex, Epidyolex) via Lyfjastofnun exemption permits; there is no pathway for cannabis flower.
Can I bring my prescribed medical cannabis into Iceland as a visitor?
For Sativex/Epidyolex, the Schengen Article 75 framework likely applies in principle, though this is not explicitly confirmed by Icelandic authorities. For flower-based products, treat this as high-risk and unconfirmed — check with Lyfjastofnun before travel.
Is a broader Icelandic medical cannabis program coming soon?
A pilot project was proposed around 2023 but has been postponed indefinitely with no confirmed timeline.